Skip to content

Roadmap for Cholesterol

Return to CVD Roadmaps Home

The WHF Roadmap for Cholesterol identifies roadblocks and suggests potential solutions to improve cardiovascular health and help reach the target set out in the Sustainable Development Goals: achieve a 30% reduction in NCDs, including CVD, by 2030.

The WHF Roadmap for Cholesterol – 2022 Update aims to reduce the global burden of atherosclerotic cardiovascular disease, which is responsible for 85% of the 20.5 million cardiovascular disease-related deaths worldwide every year. Atherosclerosis is a silent condition caused by high cholesterol that develops throughout a person’s lifespan and can lead to sudden death. The new Roadmap, which builds on the previous 2017 edition, shows how targeting cholesterol can help reduce atherosclerotic cardiovascular disease and save lives.

Latest News

Advocating for cholesterol control: A World Heart Federation toolkit

Cardiovascular disease is responsible for an estimated 18.6 million deaths every year and remains the leading cause of mortality worldwide. Raised cholesterol is widely recognized as a major risk factor for heart disease and stroke. According to the Global Burden of Disease Study, approximately 4.4 million deaths were attributable to elevated LDL cholesterol in 2019.  […]


Cholesterol risks and remedies: A Roadmap to improve cardiovascular health

Increasingly, evidence is equipping us with ways to manage our blood cholesterol levels that can mitigate or prevent dangerous cardiovascular conditions. The updated World Heart Federation Roadmap for Cholesterol delves into the epidemiology, diagnosis, treatment, and policies for better outcomes and highlights implementation case studies. The Roadmap focuses on approaches to reduce atherosclerosis and atherosclerotic […]


Taking a stance on cholesterol to curb heart disease

Cholesterol –  that waxy substance that is a type of blood fat or lipid – is mostly made by our own bodies and the rest, we get from food. Our tissues, skin, and hormones all benefit from cholesterol which gets around the body, attached to proteins. Trouble arises, however, when low-density lipoprotein (LDL) cholesterol is […]


Global Call To Action on Familial Hypercholesterolemia Aims to Improve Diagnosis and Treatment Worldwide

PASADENA, Calif., GENEVA, Switzerland,  January 2, 2020 —  The FH Foundation and the World Heart Federation announced today a Global Call to Action on familial hypercholesterolemia (FH), a vastly under-recognized and poorly managed public health concern. Published in JAMA Cardiology and authored by a global panel of scientific experts, advocacy leaders, public health officials, and […]